The group's activity appears highly profitable thanks to its outperforming net margins.
There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Historically, the company has been releasing figures that are above expectations.
Over the last seven days, analysts have been revising upwards their EPS estimates for the company.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
Based on current prices, the company has particularly high valuation levels.
With a 2020 P/E ratio at 33.22 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
For the last few months, analysts have been revising downwards their earnings forecast.
For the past year, analysts have significantly revised downwards their profit estimates.